Researchers at Texas A&M University have developed a new animal model that suggests a common viral infection may trigger brain damage and movement symptoms characteristic of Parkinson’s disease. By using the Theiler’s murine encephalomyelitis virus (TMEV), a natural pathogen in mice, scientists have identified a potential, non-toxic pathway to study how viral inflammation might contribute to the onset of neurodegenerative conditions in humans.
Parkinson’s disease is a progressive disorder that currently affects more than 10 million people worldwide, according to data from the Parkinson’s Foundation. It is recognized as the second-most common neurodegenerative disorder globally, following Alzheimer’s disease. The condition is primarily characterized by the loss of dopaminergic neurons—cells responsible for producing dopamine, a neurotransmitter essential for regulating movement, coordination, and emotional stability.
Limitations of Traditional Parkinson’s Research
For decades, scientific understanding of Parkinson’s has relied heavily on animal models that require either genetic modification or the injection of synthetic neurotoxins to induce symptoms. While these methods successfully mimic the physical manifestations of the disease, they do not always reflect the complex, multifactorial way the condition develops in humans. Many individuals exposed to environmental chemicals do not progress to Parkinson’s, suggesting that toxic-exposure models provide an incomplete picture of the disease’s etiology.
“The toxic-exposure models are useful for studying Parkinson’s, but not all people who are exposed to chemicals go on to develop Parkinson’s, so these models cannot show all the ways a disease as complex as Parkinson’s actually begins or develops over time in people,” says Candice Brinkmeyer-Langford, a neurodegenerative disease expert with the Texas A&M University School of Public Health. The study, published in the journal Brain, Behavior, and Immunity-Health, seeks to bridge this gap by exploring how the body’s long-term immune response to a pathogen might serve as a catalyst for neurological decline.
Viral Infection and Dopamine Neuron Loss
The research team utilized TMEV to observe the progression of brain damage in a controlled environment. Within one week of infection, researchers confirmed that the virus had successfully infiltrated dopamine-producing cells in the brain. By the one-month mark, these specific neurons were found to be destroyed at the site of the infection. To confirm the functional impact of this loss, the team administered a dopamine-mimicking drug to 13 infected mice and 14 healthy controls. The infected group exhibited distinct movement patterns consistent with the depletion of dopamine-producing neurons.
To further quantify the physical impact, the researchers employed the “pole test,” a standard assessment of motor coordination. Mice infected with TMEV demonstrated significantly slower completion times compared to the healthy control group. This performance gap remained evident through the 20th week of the study, indicating that the damage was not merely transient but had lasting effects on motor function.
A specialized treadmill was also used to analyze over 100 parameters related to gait, balance, and motor efficiency. The results confirmed that the viral-induced loss of dopamine neurons led to measurable physical weakness and coordination deficits. This suggests that the biological pathway initiated by the virus mirrors the physical trajectory often observed in human patients living with Parkinson’s symptoms, including tremors, stiffness, and walking difficulties.
Broader Implications for Neurodegenerative Disease
The hypothesis that viruses may trigger long-term neurological damage is not new, but this study provides a specific model to test these associations. Experts have long theorized that brain inflammation—potentially contracted years or even decades before the onset of symptoms—could play a role in the development of motor neuron diseases. This concept has gained traction in recent research, including studies on amyotrophic lateral sclerosis (ALS) conducted by the same team at Texas A&M.
“Viruses are known to cause entirely different diseases based on a person’s genetics,” Brinkmeyer-Langford notes, citing the Epstein-Barr virus as a primary example. While the Epstein-Barr virus is best known for causing mononucleosis, it has also been linked to the development of multiple sclerosis and certain cancers. Similarly, researchers have observed that SARS-CoV-2 can impact the brain and heart in addition to the respiratory system, highlighting the varied ways pathogens can affect the central nervous system.
Future Directions in Parkinson’s Research
With the validity of the TMEV model established, the next phase of research will focus on direct comparisons between this viral-based model and traditional research methods. The team plans to investigate early warning signs and biological markers that could predict the onset of Parkinson’s before severe symptoms appear. Understanding how the immune response to a viral infection alters brain chemistry over time remains a priority for the researchers.
The urgency of this work is underscored by demographic shifts. As the global population ages, the prevalence of Parkinson’s disease is projected to increase substantially, placing a growing demand on healthcare systems to find better diagnostic and preventative tools. Research for this study was supported by the National Institute for Neurological Disorders and Stroke and a graduate trainee grant from the Texas A&M College of Veterinary Medicine and Biomedical Sciences.
As the scientific community awaits further peer-reviewed studies comparing this model to existing standards, this research offers a compelling new angle on the environmental and biological triggers of neurodegeneration. Please share your thoughts or questions regarding these findings in the comments section below.